09439908 cites 4 patents.

An improved formulation of an ophthalmic composition contains riboflavin, as cross-linking agent of corneal collagen, administered by corneal iontophoresis, able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore greater therapeutic efficacy in the treatment of keratoconus.

Title
Cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus
Application Number
14/353872
Publication Number
9439908 (B2)
Application Date
October 24, 2012
Publication Date
September 13, 2016
Inventor
Pierre Roy
Paris
FR
Giulio Luciani
Bagno a Ripoli
IT
Marcello Stagni
Catania
IT
Fulvio Foschini
Rome
IT
Agent
Young & Thompson
Assignee
SOOFT ITALIA
IT
IPC
A61K 9/00
A61K 31/525
View Original Source